MIM
ICPT

Marco Investment Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Marco Investment Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,200
Closed -$362K – 183
2017
Q1 		$362K Buy
3,200
+700
+28% +$81.7K 0.06% 151
2016
Q4 		$272K Buy
2,500
+1,000
+67% +$119K 0.05% 163
2016
Q3 		$247K Buy
+1,500
New +$236K 0.04% 166
2015
Q3 		– Sell
-1,100
Closed -$266K – 195
2015
Q2 		$266K Buy
1,100
+100
+10% +$26.6K 0.04% 171
2015
Q1 		$282K Sell
1,000
-1,600
-62% -$346K 0.05% 162
2014
Q4 		$406K Buy
2,600
+800
+44% +$148K 0.05% 147
2014
Q3 		$426K Buy
1,800
+800
+80% +$204K 0.06% 134
2014
Q2 		$237K Buy
+1,000
New +$264K 0.05% 170

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Marco Investment Management's ICPT Position: Q2 2017 in Review

Marco Investment Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2017, closing a stake of 3,200 shares — an estimated $362K sold.

Marco Investment Management first reported a position in ICPT in Q2 2014 and held it in 8 quarters. The position peaked at $426K in Q3 2014. 167 funds tracked by Wall St. Rank hold ICPT as of Q2 2017.

  • Marco Investment Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2017 after selling out during the quarter.
  • Marco Investment Management sold 3,200 Intercept Pharmaceuticals, Inc. shares in Q2 2017, an estimated $362K.
  • Marco Investment Management first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2014 and held it in 8 quarters.
  • Marco Investment Management's Intercept Pharmaceuticals, Inc. position peaked at $426K in Q3 2014.
  • 167 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2017.

Based on Marco Investment Management's 13F filing for Q2 2017, filed 11 Aug 2017.